Ginolis to contribute to developing of new Mobidiag’s solution
Through the implementation of Ginolis’ cutting-edge production lines, Mobidiag, a Finnish molecular diagnostics for infectious diseases company, will be able to answer growing needs in molecular diagnostics for routine use and anticipate the production of upcoming Novodiag® test cartridges.
Ginolis Ltd, an expert in assembly automation and high precision liquid handling solutions, has signed an agreement with Mobidiag Ltd. The manufacturing solution developed for Mobidiag is based on Ginolis’ modular Xanthia automation platform. Its compact and modular design allows for high quality automation within a small footprint, saving valuable space in the clean room environment. In addition to Ginolis’ patented dispensing technology, the line is equipped with laser welding, precision assembly, ultrasonic welding and line confocal imaging (LCI) for quality inspection.
Launched in December 2017, the new Novodiag® solution from Mobidiag allows direct analysis of a patient sample placed in a disposable cartridge and delivers comprehensive results in about an hour, compared to days with well-established culture methods. Novodiag® helps make treatment decisions faster and more accurate, avoiding for example the unnecessary use of antibiotics.
“The demand for molecular diagnostics is on the rise and we are proud to continue our long-standing cooperation with Mobidiag. Both companies share a dedication to innovation and high quality. This line is a testament to the scalability of our flexible modular solutions and ability to integrate the entire manufacturing process on one platform,” says Teijo Fabritius, CEO at Ginolis.
With rapid tests and high-capacity production lines, Mobidiag is able to respond to growing requirements for infection diagnosis, including antibiotic resistance. A Novodiag® cartridge is currently under development and planned to be released in mid-2018.